ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IIN Inion Oy

0.36
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Inion Oy LSE:IIN London Ordinary Share FI0009012918 EUR0.03
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Inion Oy Share Discussion Threads

Showing 251 to 273 of 300 messages
Chat Pages: 12  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
22/4/2008
19:15
As per my previous post, this is now up 60% in a month and nobody seems to have noticed.
mikey34
31/3/2008
22:14
What going on here then? On the up?
darola
14/2/2008
10:00
Today`s announcement of shares in lieu of part salaries gives the directors plenty of incentive to get the share price moving....theyre out of pocket at this price.
mikey34
11/12/2007
16:59
irenekent(Or anybody else who may be listening)

Thought I might try to kick start some discussion here.Briefly, I`m surprised this has come back so far after seemingly beginning a recovery.There`s been some fairly promising news over the last few months.Comments?

mikey34
06/7/2007
16:03
Glad to see sales seem to be ahead of expectations. Remember that if implants don't have to be removed that saves on medical costs. I think insurance companies will be right behind these products as it could save them a fortune. One less operation means one less chance of MRSA etc!
irenekent
24/5/2007
09:22
And clearance announced today for bio-dagradable implants for the repair of all skeletal fractures excluding spinal (seperate product) in the EU. This I think could be a significant achievement as Inion can now attack the central markets for fracture repair. Hoping for a rerating - assuming the sales team get their finger out!
irenekent
15/5/2007
11:02
Another patent in the US today. There's life in this one yet!
irenekent
22/2/2007
15:02
I think they are starting to deliver on their promises. The new products, just approved in the States appear to be a core addition to the range and should significantly expand their sales. Most people would choose a biodegradable splint, if given a choice, rather than carrying around a lump of metal for the rest of their life! The rise in the share price since the announcement seems to bear out my reading of the significance of this. I just hope that they don't get taken over by the like of Smith & Nephew before we have a chance to make a profit on these.
irenekent
21/2/2007
14:05
good news today, I feel the momentum could be turning with this company..
deep powder
31/1/2007
15:40
spoke too soon, bit of life today...
deep powder
30/1/2007
15:59
all very dull at the moment...
deep powder
19/1/2007
10:28
This is a step in the right direction

--------------------------------------------------------

Inion Oy
19 January 2007


Inion Expands Biodegradable Medical Implant Product Ranges in Europe

Inion ANCHRONTM Plus Suture Anchor System receives CE Mark



Tampere, Finland and Takeley, UK. 19 January 2007...Inion (LSE: IIN.L), a
company focused on the development of novel biodegradable medical implants, has
received CE Mark from the British Standards Institution (BSI) for the Inion
ANCHRONTM Plus Suture Anchor device for both orthopaedic and sports medicine
applications. This product received equivalent 510(k) regulatory clearance for
marketing in the USA in November 2006. CE Mark is required by a number of
accredited bodies to medical device manufacturers prior to commercial
distribution in the European Union.



Inion ANCHRONTM Plus with CP-FiberTM suture is an innovative biodegradable
medical system for use in soft tissue to bone fixation (e.g. for repair of
ligament/tendon rupture or detachment) and can be used for repairing a range of
injuries. It has particular application in the shoulder, such as for rotator
cuff and instability repairs (such as Bankart and SLAP lesions). The system can
also be used to repair injuries in the elbow, ankle and knee. The high grade
CP-FiberTM suture offers special advantages over traditional polyester sutures,
including superior handling properties and increased strength.



Inion ANCHRONTM Plus supersedes Inion ANCHRONTM, Inion's first biodegradable
anchor system, and is a new addition to Inion's range of sports medicine devices
made from the Company's proprietary Inion OPTIMATM range of biomaterials. This
range includes Inion HEXALONTM, the world's first coloured biodegradable repair
device for the cruciate ligaments in the knee; Inion TRINIONTM, the
biodegradable meniscal screw for the repair of torn knee cartilage; and Inion
ANCHRONTM, which received its CE Mark and 510(k) approval in 2005.



Dr Auvo Kaikkonen, CEO of Inion commented, 'We are very pleased to have received
a CE Mark for Inion ANCHRONTM Plus, allowing patients and surgeons across Europe
access to a product that we believe offers a considerable performance advantage
over other suture anchors currently available.'



CP-FiberTM is a trademark of CP Medical, Inc., Portland, OR, USA.



-Ends-


Inion Oy

Dr Auvo Kaikkonen, Chief Executive Officer Tel: +44 1279 874 222

Dr Kirk Andriano, VP of R&D Tel: +44 1223 394 206


Citigate Dewe Rogerson Tel: +44 207 638 9571

Mark Swallow / David Dible / Helena Galilee





About Inion (www.inion.com)

Inion Oy is a Finnish company that specializes in the development of
biodegradable medical implants.



The Inion core expertise and technology lies in the design and manufacture of
innovative biodegradable plates, screws, pins and membranes that are used to
enhance the healing of skeletal injuries (bone and soft tissue), such as those
caused by trauma or by reconstructive surgery. Inion implants are made from its
proprietary Inion OptimaTM family of biomaterials, with properties tailored for
specific surgical applications, in terms of strength, flexibility and rate of
degradation.



Inion has developed and launched products in five strategic business areas -
cranio-maxillofacial surgery, orthopaedic trauma, sports medicine, dental
surgery and most recently in the spinal implant area - in nearly 50 countries
worldwide.



Inion was incorporated in early 2000 by an international team of experts in
biodegradable materials and their clinical applications, and listed on the
Official List of the UK Listing Authority in December 2004. The Company's has
operations in the UK, R&D and production facilities in Tampere, Finland, and a
US office in Oklahoma City, OK.



This announcement includes 'forward-looking statements' which include all
statements other than statements of historical facts, including, without
limitation, those regarding the Group's financial position, business strategy,
plans and objectives of management for future operations (including development
plans and objectives relating to the Group's products), and any statements
preceded by, followed by or that include forward-looking terminology such as the
words 'targets', 'believes', 'estimates', 'expects', 'aims', 'intends', 'will',
'can', 'may', 'anticipates', 'would', 'should', 'could' or similar expressions
or the negative thereof. Such forward-looking statements involve known and
unknown risks, uncertainties and other important factors beyond the Group's
control that could cause the actual results, performance or achievements of the
Group to be materially different from future results, performance or
achievements expressed or implied by such forward-looking statements. Such
forward-looking statements are based on numerous assumptions regarding the
Group's present and future business strategies and the environment in which the
Group will operate in the future. Among the important factors that could cause
the Group's actual results, performance or achievements to differ materially
from those in forward-looking statements include those relating to Inion's
funding requirements, regulatory approvals, reliance on third parties,
intellectual property, key personnel and other factors. These forward-looking
statements speak only as at the date of this announcement. The Group expressly
disclaims any obligation or undertaking to disseminate any updates or revisions
to any forward-looking statements contained in this announcement to reflect any
change in the Group's expectations with regard thereto or any change in events,
conditions or circumstances on which any such statements are based. As a result
of these factors, prospective investors are cautioned not to rely on any
forward-looking statement.

mattyfromtheblock
15/1/2007
13:27
perky today...
deep powder
12/1/2007
15:52
i still think it is in the bad but good news category, this is getting cleaned up for a deal....question is what price?
deep powder
10/1/2007
14:54
Bad news particularly (imo etc)

"The net loss for the year will be higher than expected as the Company has
decided to make a number of one-time write-offs. The value of these items is
expected to be around Euro7.0 million. This includes a deferred tax asset of Euro4.1 million."

The write off of the deferred tax asset would apparently imply that the Board do not expect the Company to be profit making in the forseeable future -

Could an accountant double check me on this and if my interpretation is wrong I will amend this posting.

pugugly
02/1/2007
16:23
Very quiet here, what's happened to all the 'takeover' boys?
deep powder
27/12/2006
15:33
latest rns, bad but good news??
deep powder
15/12/2006
05:33
grasping at straws but stock seems to be forming a base, last news announcements more positive, interesting to see result of strategic review. any fresh thoughts here?
deep powder
29/11/2006
08:37
change of CEO, it had to happen Dr Auvo Kaikkonen was obviously useless!

Don't hold but very undervalued.

eddiegoldstein
24/11/2006
13:54
its funny...barclays are quoting 21-27 for 15000 shares yet they are 24-24 on advfn.
currypata kai
24/11/2006
11:28
while things seem bleak surely the co still has substantial cash
trawl
24/11/2006
11:09
Looks like it's another classic FLOP, everyone has made a nice pile on this share except for the poor old punters who have been sold hype...god knows where the bottom is on this one probably 2p, wish my CFD was still in place!
jotoha1
24/11/2006
09:51
Who would buy them?

They don't own anything that is unique.

The CEO has yet to be fired for a catalogue of failures.

simon gordon
Chat Pages: 12  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock